Bigul

Scandent Imaging Limited - 516110 - Submission Of Revised Outcome Of Board Meeting Of 'Scandent Imaging Limited' Held On Tuesday, June 29, 2021 Commenced At 03.00 P.M. And Concluded At 5.10 P.M.

Please note that we had submitted the outcome of the Board Meeting held on Tuesday, June 29, 2021 commenced at 03.00 p.m. and concluded at 5.10 p.m. within 30 minutes of conclusion of the meeting i.e. at 5. 26 p.m. but due to inadvertent reasons, a different file was uploaded which was exclusive of the following additional points: 1. Appointment of Dr. Rajeev Singh as Non Executive Non Independent Director of the Company. 2. Appointment of Dr. Rahul Sathe as a Non Executive Non Independent Director of the Company. However, the above information was uploaded on the website under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 within 30 minutes of the conclusion of the meeting. Thus, it was not the result of any intentional act and was done inadvertently. We request you to kindly consider the revised outcome enclosed herewith on your records and oblige.
29-06-2021
Bigul

Scandent Imaging Limited - 516110 - Announcement under Regulation 30 (LODR)-Change in Directorate

1. Appointment of Dr. Rajeev Singh as Non Executive Non Independent Director of the Company. Dr. Rajeev Singh has been appointed as a Non-Executive Non-Independent Director of the Company liable to retire by rotation with effect from June 29, 2021 subject to the approval of Shareholders at the forthcoming Annual General Meeting. Dr. Rajeev Singh is not debarred from holding the Office of Director by virtue of any order passed by SEBI or any other such authority. . 1. Appointment of Dr. Rahul Sathe as a Non Executive Non Independent Director of the Company. Dr. Rahul Sathe has been appointed as a Non-Executive Non-Independent Director liable of the Company to retire by rotation with effect from June 29, 2021 subject to the approval of Shareholders at the forthcoming Annual General Meeting. Dr. Rahul Sathe is not debarred from holding the Office of Director by virtue of any order passed by SEBI or any other such authority.
29-06-2021
Bigul

Scandent Imaging Limited - 516110 - The Audited Financial Results For The Fourth Quarter And Financial Year Ended On March 31, 2021

1. The Audited financial results for the Fourth Quarter and Financial Year ended on March 31, 2021 of the financial Year 2020-21 in the format specified under Regulation 33 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015; 2. Audit Report issued by M/s. M. B. Agrawal & Co., Chartered Accountants, the Statutory Auditors of the Company on the Audited financial results for the Fourth quarter and Financial Year ended on March 31, 2021; and 3. Declaration regarding the Auditor''s report with unmodified opinion on the Audited Financial Results for the Financial Year ended on March 31, 2021 pursuant to Regulation 33(3)(d) of the SEBI (LODR) Regulations, 2015.
29-06-2021
Bigul

Scandent Imaging Limited - 516110 - Outcome Of Board Meeting Held On Tuesday, June 29, 2021

The Board of Directors at its Meeting held on Tuesday, June 29, 2021 considered and after due deliberation approved the following: 1. The Audited financial results for the Fourth Quarter and Financial Year ended on March 31, 2021 of the financial Year 2020-21 in the format specified under Regulation 33 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015; 2. Audit Report issued by M/s. M. B. Agrawal & Co., Chartered Accountants, the Statutory Auditors of the Company on the Audited financial results for the Fourth quarter and Financial Year ended on March 31, 2021; and 3. Declaration regarding the Auditor''s report with unmodified opinion on the Audited Financial Results for the Financial Year ended on March 31, 2021 pursuant to Regulation 33(3)(d) of the SEBI (LODR) Regulations, 2015. We request you to take this information on records.
29-06-2021
Bigul

Scandent Imaging Ltd - 516110 - Compliances-Reg.24(A)-Annual Secretarial Compliance

With reference to the above subject and in terms of the SEBI circular vide: No.CIR/CFD/CMDI/27/2019 dated 8th February, 2019. We are submitting herewith the Annual Secretarial Compliance Report of the Company for the year ended 31st March, 2021, issued by M/s. Ajay Kumar & Co., Practicing Company Secretaries.
24-06-2021
Bigul

Scandent Imaging Limited - 516110 - Board Meeting Intimation for Approval Of Financial Results For Fourth Quarter And Financial Year Ended 31.03.2021

Scandent Imaging Limitedhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/06/2021 ,inter alia, to consider and approve 1. Audited Financial Results of the Company for the fourth quarter and financial year ended 31st March, 2021 alongwith the Audited report; 2. Any other matter with the permission of the Chair.
23-06-2021
Bigul

Scandent Imaging Limited - 516110 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Intimation is given pursuant to Regulation 40 and Schedule VII of Securities and Exchange Board of India (Listing Obligation and Disclosure Requirement) Regulation, 2015, regarding newspaper advertisement (in Business Standard and Mumbai Lakshadeep) for proposed Transfer of Shares. Kindly take the above in your record.
12-05-2021
Bigul

Scandent Imaging Limited - 516110 - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements), Regulations, 2015

This is to inform you that Dr. Rajeev Agarwal (DIN: 09110611) had given his consent to act as a Non Executive Non Independent director of the Company and the Board of directors in its meeting held on 26th April, 2021 approved the said appointment but due to some personal reasons and some unavoidable circumstances, Dr. Rajeev Agarwal vide his letter dated 11th May, 2021 informed the Company that he wishes to withdraw his consent to act as director and has requested the board to stop the appointment formalities further. Thus, taking this on records, we would like to cancel his appointment on the Board. Kindly take note on the same
11-05-2021
Bigul

Scandent Imaging Limited - 516110 - Announcement under Regulation 30 (LODR)-Cessation

Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations') read with Para A of Part A of Schedule III to the Listing Regulations, we wish to inform that Dr. Gaurav Goyal (DIN: 07246231) has stepped down from the position of the 'Non-Executive Independent Director' of the Company with effect from today, i.e., May 10, 2021. The Board of Directors of the Company appreciates his valuable contribution and support during his term as the Director of the Company.
10-05-2021
Bigul

Scandent Imaging Ltd - 516110 - Announcement under Regulation 30 (LODR)-Cessation

This is to inform you that Dr. Sowmya Deshpande (DIN: 00705918) has resigned from the post of Whole Time Director of the Company due to pre-occupation. The resignation is effective from April 26, 2021. The details required under Regulation 30 of the Listing Regulations read with SEBI Circular No. CIR/CFD/CMD/4/2015 dated September 09, 2015 is given as under: Sr. No. Name of the Director Disclosure Requirement Details 1. Dr. Sowmya Deshpande Reason for Change Resignation due preoccupation Date of cessation April 26, 2021 Further, the Company has received confirmation from Dr. Sowmya Deshpande that there are no other material reasons for her resignation other that those which is provided in the resignation letter. The Board of the Directors has noted the above resignations express its sincere appreciation for Dr. Deshpande's valuable services, guidance and contribution to the Company during their tenure as a member of the Board.
26-04-2021
Next Page
Close

Let's Open Free Demat Account